Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iovance Biotherapeutics (IOVA) Tax Provisions: 2023-2024

Historic Tax Provisions for Iovance Biotherapeutics (IOVA) over the last 2 years, with Dec 2024 value amounting to -$2.8 million.

  • Iovance Biotherapeutics' Tax Provisions fell 58.22% to -$2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$671,000, marking a year-over-year increase of 89.19%. This contributed to the annual value of -$2.8 million for FY2024, which is 19.20% up from last year.
  • According to the latest figures from FY2024, Iovance Biotherapeutics' Tax Provisions is -$2.8 million, which was up 19.20% from -$3.5 million recorded in FY2023.
  • In the past 5 years, Iovance Biotherapeutics' Tax Provisions ranged from a high of -$2.8 million in FY2024 and a low of -$3.5 million during FY2023.
  • Over the past 2 years, Iovance Biotherapeutics' median Tax Provisions value was -$3.2 million (recorded in 2023), while the average stood at -$3.2 million.
  • Data for Iovance Biotherapeutics' Tax Provisions shows a peak YoY increased of 19.20% (in 2024) over the last 5 years.
  • Iovance Biotherapeutics' Tax Provisions (Yearly) stood at -$3.5 million in 2023, then rose by 19.20% to -$2.8 million in 2024.